Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00812
|
|||||
| Drug Name |
Brecanavir
|
|||||
| Synonyms |
(3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL [(1S,2R)-3-[(1,3-BENZODIOXOL-5-YLSULFONYL)(ISOBUTYL)AMINO]-2-HYDROXY-1-{4-[(2-METHYL-1,3-THIAZOL-4-YL)METHOXY]BENZYL}PROPYL]CARBAMATE; 2fdd; 2fde; 313682-08-5; AC1NX470; AKOS005145761; BDBM4685; Brecanavir; Brecanavir (USAN); Brecanavir [USAN:INN]; CHEMBL206031; D03253; DB04887; DTXSID10185296; E367I8C7FI; GSK 640385; GW 0385; GW0385; GW640385; GW64085X; JORVRJNILJXMMG-OLNQLETPSA-N; Proteinase inhibitor 640385; SCHEMBL1533991; UNII-E367I8C7FI; VX 385; VX-385; ZINC3994828; [3H]GW0385
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C33H41N3O10S2
|
|||||
| Canonical SMILES |
CC1=NC(=CS1)COC2=CC=C(C=C2)CC(C(CN(CC(C)C)S(=O)(=O)C3=CC4=C(C=C3)OCO4)O)NC(=O)OC5COC6C5CCO6
|
|||||
| InChI |
InChI=1S/C33H41N3O10S2/c1-20(2)14-36(48(39,40)25-8-9-29-30(13-25)45-19-44-29)15-28(37)27(35-33(38)46-31-17-43-32-26(31)10-11-41-32)12-22-4-6-24(7-5-22)42-16-23-18-47-21(3)34-23/h4-9,13,18,20,26-28,31-32,37H,10-12,14-17,19H2,1-3H3,(H,35,38)/t26-,27-,28+,31-,32+/m0/s1
|
|||||
| InChIKey |
JORVRJNILJXMMG-OLNQLETPSA-N
|
|||||
| CAS Number |
CAS 313682-08-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 703.8 | Topological Polar Surface Area | 192 | ||
| Heavy Atom Count | 48 | Rotatable Bond Count | 15 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 13 | |||
| XLogP |
4.4
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.